Patents by Inventor Guenther Schlag

Guenther Schlag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110190812
    Abstract: The present invention provides a fibrinogen-based tissue adhesive which contains an elastase inhibitor.
    Type: Application
    Filed: February 4, 2011
    Publication date: August 4, 2011
    Applicant: Baxter Aktiengesellschaft
    Inventors: Heinz REDL, Guenther Schlag, Irmgard Schlag, Johann Eibl
  • Patent number: 7892802
    Abstract: The present invention provides a fibrinogen-based tissue adhesive which contains an elastase inhibitor.
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: February 22, 2011
    Assignee: Baxter Aktiengesellschaft
    Inventors: Heinz Redl, Guenther Schlag, Irmgard Schlag, legal representative, Johann Eibl
  • Publication number: 20090041748
    Abstract: The present invention provides a fibrinogen-based tissue adhesive which contains an elastase inhibitor.
    Type: Application
    Filed: October 16, 2008
    Publication date: February 12, 2009
    Applicant: Baxter Aktiengesellschaft
    Inventors: Heinz Redl, Guenther Schlag, Irmgard Schlag, Johann Eibl
  • Publication number: 20060216280
    Abstract: The present invention provides a fibrinogen-based tissue adhesive which contains an elastase inhibitor.
    Type: Application
    Filed: May 30, 2006
    Publication date: September 28, 2006
    Applicant: Baxter Aktiengesellschaft
    Inventors: Heinz Redl, Guenther Schlag, Johann Eibl
  • Patent number: 7091015
    Abstract: The present invention provides a fibrinogen-based tissue adhesive which contains an elastase inhibitor.
    Type: Grant
    Filed: August 26, 1998
    Date of Patent: August 15, 2006
    Assignee: Baxter Aktiengesellschaft
    Inventors: Heinz Redl, Guenther Schlag, Johann Eibl
  • Patent number: 6649162
    Abstract: The invention relates to a hemostatic sponge based on collagen and an activator or proactivator of blood coagulation homogeneously distributed therein, which is dried and contains a water content of at least 2%, preferably in the range of 2 to 25%, more preferred 10 to 20%, and a method for producing this sponge.
    Type: Grant
    Filed: March 29, 2000
    Date of Patent: November 18, 2003
    Assignee: Baxter Aktiengesellschaft
    Inventors: Wolfgang Biering, Hamza Mansour, Guenther Schlag, Thomas Seelich, Edgar Scheel, Georg Habison
  • Patent number: 6358918
    Abstract: There is disclosed a stable, virus-safe, pharmaceutical preparation comprising thiol-group-containing proteins which are heat-treated and processed such that at least 40% of the thiol groups are capable of being nitrosated, a method of preparing such preparations as well as the use of these preparations.
    Type: Grant
    Filed: July 5, 2000
    Date of Patent: March 19, 2002
    Assignee: Baxter Aktiengesellschaft
    Inventors: Guenther Schlag, Seth Hallstroem, Harald Gasser
  • Patent number: 6124255
    Abstract: There is disclosed a stable, virus-safe, pharmaceutical preparation comprising thiol-group-containing proteins which are heat-treated and processed such that at least 40% of the thiol groups are capable of being nitrosated, a method of preparing such preparations as well as the use of these preparations.
    Type: Grant
    Filed: January 16, 1998
    Date of Patent: September 26, 2000
    Assignee: Baxter Aktiengesellschaft
    Inventors: Guenther Schlag, Seth Hallstroem, Harald Gasser